AMY KRUSE

Profile

First Name

: AMY

Middle Name

:

Last Name

: KRUSE

Related Companies
Titles
Company Name
Related People
DIRECTOR
GILGAMESH PHARMACEUTICALS, INC.
ROBERT BERMAN, GAETANO CRUPI, YONI FALKSON, LASZLO KISS, ANDREW KRUEGEL, ANDREW KRUEGEL, PH.D., GERARD MAREK, THOMAS KEVIN MURPHY, THOMAS KEVIN MURPHY, PH.D., DALIBOR SAMES, PHIL SKOLNICK, JONATHAN SPORN, JONATHAN SPORN, M.D.
DIRECTOR
PARADROMICS, INC.
MATT ANGLE, MATTHEW ANGLE, MATTHEW R ANGLE, ENKE BASHLLARI, ENKELEJDA BASHLLARI, JAMES BURROWS, HELMY ELTOUKHY, EDMUND HUBER, ZIA HUQUE, ADAM KABLANIAN, RON KELLY, YIFAN KONG, THOMAS KRUMMEL, DAKIN SLOSS, COURT WESTCOTT
DIRECTOR
IRIDIA, INC.
STEVE BARNARD, CHRIS CAMARSH, JAY FLATLEY, STEPHANIE ANN GEORGE, JAMES P LINTON, JAMES P. LINTON, PETER LONGO, MARC-FRANCOIS PELLETIER, MURALI PRAHALAD, PAUL PREDKI, GWEN RUFF, PAUL YOOK
DIRECTOR
COGNIXION CORP
ANDREAS FORSLAND, THOMAS GRUBER, JEFFREY KRAUT, THOMAS LADD, DIANA PEREIRA, THOMAS WASHING, THOMAS G WASHING, TOM WASHING, LEONARD ZERMAN
DIRECTOR
MORPHOCEUTICALS, INC.
TAMIM HAMAD J.J AL-THANI, JUSTIN BRIGGS, DAVID GILL, MICHAEL R. HUFFORD, ROSEMARIE HUNZIKER, JAMES JENSON, DAVID KAPLAN, MICHAEL LEVIN, ALEXANDER PICKETT
EXECUTIVE OFFICER
SATORI NEURO PARTNERS LP
EDMUND RUGGER BURKE, RANDY EISENMAN, JAMES HADDAWAY, WILLIE HOUSTON III, GP, LLC SATORI NEURO PARTNERS, LLC SATORI NEURO PARTNERS GP,, SUNNY VANDERBECK
DIRECTOR
MOTIF NEUROTECH, INC.
ANTHONY ARNOLD, JACOB ROBINSON, THOMAS M. SHEHAB
EXECUTIVE OFFICER
SATORI NEURO CO-INVEST LP
EDMUND RUGGER BURKE, RANDY EISENMAN, JAMES HADDAWAY, WILLIE HOUSTON III, GP, LLC SATORI NEURO PARTNERS, LLC SATORI NEURO PARTNERS GP,, SUNNY VANDERBECK
DIRECTOR
GILGAMESH PHARMA INC.
ROBERT BERMAN, ZIA HUQUE, ANDREW KRUEGEL, PHIL SKOLNICK, JONATHAN SPORN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2026-03-27 
2026-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-09 
2026-02-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-02 
2025-12-23
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-05-01 
2025-12-23
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-09-01 
2025-01-10
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-31 
2024-12-31
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-09-01 
2024-12-30
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-31 
2024-06-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-31 
2024-01-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2023-11-07
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-21 
2023-05-11
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-05-01 
2023-04-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-21 
2023-01-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-13 
2022-09-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-02-17 
2022-05-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-16 
2022-02-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-04 
2021-11-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-12 
2021-11-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-12 
2021-10-19
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-15 
2021-07-23
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-15 
2021-05-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-26